School of Exercise and Nutrition Sciences, Faculty of Health, Queensland University of Technology, Victoria Park Road, Kelvin Grove, QLD 4058, Australia.
Mary Mackillop Institute for Health Research, Australian Catholic University, Level 5, 215 Spring Street, Melbourne, VIC 3000, Australia.
Nutrients. 2024 May 9;16(10):1423. doi: 10.3390/nu16101423.
In individuals with McArdle disease (IWMD), the ingestion of carbohydrates before exercise has previously been shown in laboratory studies to significantly decrease the exercising symptoms of the condition and increase exercise tolerance during the early stages of exercise. As a result, carbohydrate ingestion pre-exercise is currently included in management guidelines, and often advised by medical professionals treating the condition. The aim of the current study was to determine whether positive lab-based results for the ingestion of carbohydrate before exercise in laboratory studies are being effectively translated into practice and produce perceptions of the same positive outcomes in real-world settings (RWS). An online survey method was used to collect responses from 108 IWMD. Data collected on the amount and type of carbohydrate consumed prior to exercise found that most surveyed participants (69.6%) who supplied qualitative data ( = 45) consumed less than the 37 g currently recommended in management guidelines. Survey data also revealed a large variation in the type and amount of carbohydrate ingested when IWMDs are applying carbohydrate ingestion before exercise in RWS. Consistent with these findings, only 17.5% of participants stated that they found carbohydrate ingestion before exercise relieved or minimised their MD symptoms. Results suggest that positive lab-based findings (increased exercise tolerance) of carbohydrate ingestion before exercise are not being effectively translated to RWS for many IWMD. There is a need for improved patient education of IWMD on the application of carbohydrate ingestion before exercise in RWS.
在 McArdle 病(IWMD)患者中,之前的实验室研究表明,在运动前摄入碳水化合物可显著减轻该疾病的运动症状,并在运动早期增加运动耐量。因此,运动前摄入碳水化合物目前已被纳入管理指南,并经常被治疗该疾病的医疗专业人员所建议。本研究旨在确定在实验室研究中,运动前摄入碳水化合物的积极实验室结果是否有效转化为实际应用,并在真实世界环境(RWS)中产生相同的积极结果的看法。采用在线调查方法,从 108 名 IWMD 患者中收集了反应。在运动前摄入碳水化合物的量和类型上收集的数据发现,大多数提供定性数据的调查参与者(69.6%,n=45)摄入的碳水化合物少于管理指南中目前推荐的 37 克。调查数据还揭示了 IWMD 在 RWS 中应用运动前碳水化合物摄入时,碳水化合物的类型和量存在很大差异。与这些发现一致的是,只有 17.5%的参与者表示,他们发现运动前摄入碳水化合物缓解或最小化了他们的 MD 症状。结果表明,对于许多 IWMD 患者,运动前摄入碳水化合物的积极实验室结果(增加运动耐量)并没有有效地转化为 RWS。需要加强对 IWMD 患者在 RWS 中应用运动前碳水化合物摄入的教育。